Riko Kitazawa
Impact in
- Nephrology top 1%
- Parathyroid Disorders and Treatments
-
- Bone health and osteoporosis research
Papers in
- Oncology 68
- Bone health and treatments 45
- Nephrology 17
- Parathyroid Disorders and Treatments 11
- Co-authors
- Sohei KitazawaSakan MaedaTakeshi KondoMasafumi FukagawaHideki FujiiRyuma HaraguchiKazuo ChiharaJ L Vannice
- Journals
- Histochemistry and Cell Biology (12 papers)Biochemical and Biophysical Research Communications (9 papers)Journal of Cellular Biochemistry (7 papers)Bone (6 papers)Neurosurgical Review (6 papers)
- Partner nations
- JapanUnited StatesChina
In The Last Decade
Riko Kitazawa
213 papers receiving 5.5k citations
Peers
Comparison fields: 5 of 133
- Nephrology 570
- Orthopedics and Sports Medicine 494
- Oncology 1.5k
- Cancer Research 638
- Molecular Biology 2.7k
Countries citing papers authored by Riko Kitazawa
This map shows the geographic impact of Riko Kitazawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Riko Kitazawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Riko Kitazawa more than expected).
Fields of papers citing papers by Riko Kitazawa
This network shows the impact of papers produced by Riko Kitazawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Riko Kitazawa. The network helps show where Riko Kitazawa may publish in the future.
Co-authors
The 25 scholars most cited alongside Riko Kitazawa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 3 | |
| 4 | 2023 | 8 | |
| 5 | 2023 | 2 | |
| 6 | 2023 | 21 | |
| 7 | 2023 | 4 | |
| 8 | 2022 | 0 | |
| 9 | 2021 | 4 | |
| 10 | 2021 | 13 | |
| 11 | 2018 | 27 | |
| 12 | 2018 | 40 | |
| 13 | 2018 | 3 | |
| 14 | 2014 | 0 | |
| 15 | 2013 | 2 | |
| 16 | 2013 | 6 | |
| 17 | 2011 | 64 | |
| 18 | Successful Management of Humoral Hypercalcemia of Malignancy in A Patient with Ovarian Cancer | 2000 | 3 |
| 19 | 1999 | 7 | |
| 20 | 1992 | 16 |
About Riko Kitazawa
Riko Kitazawa is a scholar working on Oncology, Nephrology, Genetics, Cancer Research and Rheumatology, having authored 230 papers that have together received 5.6k indexed citations. Recurring topics across this work include Bone health and treatments (45 papers), Bone Metabolism and Diseases (39 papers), Glioma Diagnosis and Treatment (22 papers), Epigenetics and DNA Methylation (15 papers), NF-κB Signaling Pathways (14 papers), Cancer-related gene regulation (14 papers), TGF-β signaling in diseases (13 papers) and Parathyroid Disorders and Treatments (11 papers). The work is most often cited by research in Nephrology (570 citations), Orthopedics and Sports Medicine (494 citations), Oncology (1.5k citations), Cancer Research (638 citations) and Molecular Biology (2.7k citations). Riko Kitazawa has collaborated with scholars based in Japan, United States and China. Frequent co-authors include Sohei Kitazawa, Sakan Maeda, Takeshi Kondo, Masafumi Fukagawa, Hideki Fujii, Ryuma Haraguchi, Kazuo Chihara, J L Vannice, Robert B. Kimble and Yutaka Takahashi. Their work appears in journals such as Histochemistry and Cell Biology, Biochemical and Biophysical Research Communications, Journal of Cellular Biochemistry, Bone and Neurosurgical Review.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.